Vyant Bio Inc. buy tamam
Start price
07.12.17
/
50%
€303.08
Target price
07.12.18
€811.80
Performance (%)
-90.00%
End price
07.12.18
€30.30
Summary
This prediction ended on 07.12.18 with a price of €30.30. Massive losses of -90.00% were the result for the BUY prediction by tamam. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Vyant Bio Inc. | - | - | - | - |
| iShares Core DAX® | 2,99 % | 3,22 % | 4,27 % | 53,70 % |
| iShares Nasdaq 100 | -1,58 % | -3,17 % | 24,75 % | 76,70 % |
| iShares Nikkei 225® | -2,25 % | -9,92 % | 43,52 % | 60,79 % |
| iShares S&P 500 | -0,01 % | 1,64 % | 20,97 % | 62,81 % |
Comments by tamam for this prediction
In the thread Cancer Genetics Inc. diskutieren
tamam stimmt der Buy-Einschätzung von melinda zu
tamam stimmt am 07.12.2017 der Buy-Einschätzung von melinda aber mit dem Kursziel 6 $ zu.
Überschrift: diagnostics
Cancer Genetics (NASDAQ:CGIX) initiated with Buy rating and $6 (179% upside) price target by Maxim Group.
(Laufzeit überschritten)